Biomarker-based clinical trials provide efficiencies during therapeutic development and form the foundation for precision medicine. These trials must generate information on both experimental ...
New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL ...
WILMINGTON, N.C. & COLLEGE STATION, Texas--(BUSINESS WIRE)-- PPD, Inc. (Nasdaq: PPDI) and Berry Consultants, LLC today announced they have entered into a collaboration in the area of Bayesian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results